{"id":"intravenous-lipid","safety":{"commonSideEffects":[{"rate":"null","effect":"Infection"},{"rate":"null","effect":"Allergic reactions"},{"rate":"null","effect":"Metabolic disturbances"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"They are used to provide nutritional support, especially in patients who have difficulty absorbing nutrients through the digestive system. This can be due to various conditions such as short bowel syndrome or severe pancreatitis.","oneSentence":"Intravenous lipid emulsions provide a source of calories and essential fatty acids.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:48:43.998Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Parenteral nutrition for patients who cannot receive feedings or fluids by mouth"}]},"trialDetails":[{"nctId":"NCT02728635","phase":"NA","title":"Epigenetic Regulation of Human Adipose Tissue Distribution","status":"ACTIVE_NOT_RECRUITING","sponsor":"AdventHealth Translational Research Institute","startDate":"2016-07","conditions":"Obesity","enrollment":27},{"nctId":"NCT07492316","phase":"PHASE1","title":"RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)","status":"NOT_YET_RECRUITING","sponsor":"University of Florida","startDate":"2026-05-15","conditions":"Recurrent Medulloblastoma","enrollment":24},{"nctId":"NCT07491172","phase":"PHASE1","title":"A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias","status":"RECRUITING","sponsor":"CRISPR Therapeutics AG","startDate":"2024-06-21","conditions":"Cardiovascular, Metabolic Disease, Dyslipidemias","enrollment":90},{"nctId":"NCT00862433","phase":"PHASE1","title":"Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2014-10-10","conditions":"Diabetes, Fatty Liver, Obesity","enrollment":50},{"nctId":"NCT03663335","phase":"PHASE2","title":"Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-11-28","conditions":"Kidney Transplantation","enrollment":418},{"nctId":"NCT07487675","phase":"PHASE2","title":"Evaluation of Intravenous Sodium Valproate on Interleukin-6 Levels in Patients With TMJ Disc Displacement","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tanta University","startDate":"2024-09-29","conditions":"Temporomandibular Joint Internal Derangement (ADWR)","enrollment":10},{"nctId":"NCT05421858","phase":"PHASE3","title":"A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.","status":"RECRUITING","sponsor":"Basilea Pharmaceutica","startDate":"2024-12-11","conditions":"Candidemia, Candidiasis, Invasive","enrollment":450},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT04573140","phase":"PHASE1","title":"A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2021-12-13","conditions":"Adult Glioblastoma, High Grade Glioma, WHO Grade III or IV Malignant Glioma","enrollment":28},{"nctId":"NCT03663933","phase":"PHASE2","title":"Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-09-04","conditions":"Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders","enrollment":71},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT07475949","phase":"PHASE3","title":"Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":352},{"nctId":"NCT07475936","phase":"","title":"Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":392},{"nctId":"NCT07470385","phase":"","title":"Effects of Lipid Emulsions on Coagulation","status":"COMPLETED","sponsor":"Mimi Tang, PhD","startDate":"2025-05-23","conditions":"Coagulation Disorder, Coagulation Function","enrollment":6259},{"nctId":"NCT07340463","phase":"PHASE2","title":"The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment","status":"RECRUITING","sponsor":"Nanjing University School of Medicine","startDate":"2025-12-08","conditions":"Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)","enrollment":50},{"nctId":"NCT07436364","phase":"EARLY_PHASE1","title":"Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy","status":"NOT_YET_RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2026-03","conditions":"Soft Tissue Sarcoma","enrollment":10},{"nctId":"NCT07448298","phase":"EARLY_PHASE1","title":"A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases","status":"RECRUITING","sponsor":"Beijing Boren Hospital","startDate":"2026-03-09","conditions":"Relapsed/Refractory Autoimmune Diseases","enrollment":18},{"nctId":"NCT06059846","phase":"PHASE3","title":"A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)","status":"COMPLETED","sponsor":"Spero Therapeutics","startDate":"2023-12-21","conditions":"Urinary Tract Infection, Acute Pyelonephritis","enrollment":1690},{"nctId":"NCT07461727","phase":"PHASE1","title":"An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of EDB-102 in Patients With EGFR L858R-Mutant, Third-Generation TKI-Resistant Advanced Non-Small Cell Lung Cancer With Liver Metastases","status":"NOT_YET_RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2026-02-10","conditions":"Non-Small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer, Liver Metastases","enrollment":15},{"nctId":"NCT07450469","phase":"","title":"Field Study on Intravenous Iloprost for Treatment of Severe Frostbite at High Altitude","status":"NOT_YET_RECRUITING","sponsor":"Institute of Mountain Emergency Medicine","startDate":"2026-05","conditions":"Frostbite, Altitude, Field Physician Care","enrollment":10},{"nctId":"NCT05039619","phase":"PHASE2","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2022-05-12","conditions":"Lupus Nephritis","enrollment":40},{"nctId":"NCT07408336","phase":"EARLY_PHASE1","title":"Clinical Study of AFN50 Injection in the Autoimmune Diseases","status":"RECRUITING","sponsor":"AlphaNa Bioscience Company Limited","startDate":"2026-02-04","conditions":"Autoimmune Diseases","enrollment":18},{"nctId":"NCT03249831","phase":"PHASE1","title":"A Blood Stem Cell Transplant for Sickle Cell Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2019-01-04","conditions":"Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies","enrollment":3},{"nctId":"NCT03644667","phase":"PHASE2","title":"Tocilizumab in Cardiac Transplantation","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-12-20","conditions":"Heart Transplant","enrollment":385},{"nctId":"NCT06055608","phase":"PHASE2","title":"Advancing Transplantation Outcomes in Children","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-05-22","conditions":"Kidney Transplant","enrollment":200},{"nctId":"NCT07440069","phase":"PHASE4","title":"Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor","status":"RECRUITING","sponsor":"Universidad Nacional Autonoma de Honduras","startDate":"2026-02-15","conditions":"Labor Pain","enrollment":300},{"nctId":"NCT05156710","phase":"PHASE2","title":"BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2022-06-09","conditions":"Transplant Rejection","enrollment":48},{"nctId":"NCT06279793","phase":"PHASE2","title":"Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients","status":"RECRUITING","sponsor":"GCP-Service International West GmbH","startDate":"2024-02-15","conditions":"Intensive Care Unit, Coronary Artery Bypass Grafting (CABG), High Risk Patients","enrollment":550},{"nctId":"NCT06693752","phase":"PHASE2","title":"CEUS Evaluation of Hydrocephalus in Neonates and Infants","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2026-03-31","conditions":"Hydrocephalus in Infants, Hydrocephalus Acquired","enrollment":20},{"nctId":"NCT07366359","phase":"NA","title":"PGE2 Followed by Oxytocin vs Oxytocin in Term PROM (POXY-PROM)","status":"RECRUITING","sponsor":"National Hospital of Obstetrics and Gynecology","startDate":"2026-02-10","conditions":"Premature Rupture of Fetal Membranes, Labor, Induced, Cervical Ripening","enrollment":450},{"nctId":"NCT06808087","phase":"","title":"Management of Acute Appendicitis Pain in the Emergency Department","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2024-05-08","conditions":"Acute Appendicitis","enrollment":96},{"nctId":"NCT04961593","phase":"","title":"PK/PD of Caspofungin in Children Severe Infection","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2022-10-01","conditions":"Pharmacokinetics, Infection, Fungal","enrollment":60},{"nctId":"NCT03504241","phase":"PHASE1","title":"Tolerance by Engaging Antigen During Cellular Homeostasis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-07-30","conditions":"Kidney Transplantation, Renal Transplantation, Renal Transplant Recipient","enrollment":8},{"nctId":"NCT07176923","phase":"EARLY_PHASE1","title":"CS-121 APOC3 Base Editing in FCS","status":"RECRUITING","sponsor":"CorrectSequence Therapeutics Co., Ltd","startDate":"2025-10-15","conditions":"Familial Chylomicronemia Syndrome (FCS)","enrollment":15},{"nctId":"NCT06052956","phase":"PHASE2","title":"Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-07-15","conditions":"Abscess","enrollment":120},{"nctId":"NCT07394491","phase":"NA","title":"Intravenous Paracetamol Versus Intramuscular Tramadol in Shortening the Duration of Labour.","status":"COMPLETED","sponsor":"Federal Teaching Hospital Abakaliki","startDate":"2022-11-01","conditions":"Labour Duration","enrollment":189},{"nctId":"NCT07386288","phase":"NA","title":"Short-term Perfusion Effects: Dexketoprofen/Tramadol","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2024-11-01","conditions":"Renal Colic","enrollment":102},{"nctId":"NCT04601051","phase":"PHASE1","title":"Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM)","status":"COMPLETED","sponsor":"Intellia Therapeutics","startDate":"2020-11-05","conditions":"Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy, Wild-Type Transthyretin Cardiac Amyloidosis","enrollment":72},{"nctId":"NCT03842696","phase":"PHASE1, PHASE2","title":"Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2020-02-04","conditions":"Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase","enrollment":43},{"nctId":"NCT06572267","phase":"PHASE2","title":"Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease","status":"RECRUITING","sponsor":"Xijing Hospital","startDate":"2024-10-16","conditions":"Coronary Artery Disease","enrollment":18},{"nctId":"NCT04486833","phase":"PHASE1, PHASE2","title":"Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib","status":"RECRUITING","sponsor":"Genprex, Inc.","startDate":"2021-09-03","conditions":"Carcinoma, Non-Small Cell Lung","enrollment":158},{"nctId":"NCT07353281","phase":"NA","title":"Carbetocin vs Misoprostol for Postpartum Hemorrhage Prevention","status":"NOT_YET_RECRUITING","sponsor":"Western Galilee Hospital-Nahariya","startDate":"2026-01-31","conditions":"Postpartum Complication, Postpartum Hemorrhage","enrollment":146},{"nctId":"NCT03292861","phase":"PHASE2","title":"The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients","status":"ENROLLING_BY_INVITATION","sponsor":"Cedars-Sinai Medical Center","startDate":"2018-09-13","conditions":"Heart Transplantation","enrollment":60},{"nctId":"NCT03997383","phase":"PHASE3","title":"APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alnylam Pharmaceuticals","startDate":"2019-09-12","conditions":"Transthyretin Amyloidosis (ATTR) With Cardiomyopathy","enrollment":360},{"nctId":"NCT07332572","phase":"PHASE4","title":"COMPARISON OF INTRAVENOUS DEXMEDETOMEDINE AND TRAMADOL FOR POST OPERATIVE SHIVERING AFTER SPINAL ANESTHESIA FOR CAESAREAN SECTION","status":"COMPLETED","sponsor":"Liaquat National Hospital & Medical College","startDate":"2025-06-01","conditions":"Shivering Caused by Spinal Anesthesia","enrollment":100},{"nctId":"NCT06977126","phase":"PHASE1","title":"Study to Assess the Safety and Effects of Porphysome Nanoparticles for Imaging in Gynaecological Cancers","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-11-18","conditions":"Gynecological Cancers","enrollment":24},{"nctId":"NCT07322835","phase":"","title":"Efficacy and Safety of Reperfusion Therapy for Minor Ischemic Stroke in China","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2026-01-01","conditions":"Minor Ischemic Stroke","enrollment":5400},{"nctId":"NCT06671093","phase":"PHASE1","title":"Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B","status":"RECRUITING","sponsor":"Tune Therapeutics, Inc.","startDate":"2024-11-29","conditions":"Chronic Hep B, Chronic Hepatitis b, Chronic Hepatitis","enrollment":36},{"nctId":"NCT07225114","phase":"PHASE2","title":"Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging","status":"RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2025-11-04","conditions":"Breast Cancer, Kidney Neoplasms, Liver Neoplasms","enrollment":40},{"nctId":"NCT02990286","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2017-01-20","conditions":"Lung Disease, Interstitial","enrollment":122},{"nctId":"NCT05178862","phase":"PHASE3","title":"A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole","status":"TERMINATED","sponsor":"Scynexis, Inc.","startDate":"2022-08-03","conditions":"Candidiasis, Invasive, Candidemia","enrollment":68},{"nctId":"NCT06634420","phase":"PHASE3","title":"HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Intellia Therapeutics","startDate":"2025-01-15","conditions":"Hereditary Angioedema","enrollment":60},{"nctId":"NCT03490929","phase":"PHASE4","title":"CEUS for Blunt Abdominal Trauma in Children","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2018-06-01","conditions":"Trauma Abdomen","enrollment":146},{"nctId":"NCT06714357","phase":"PHASE2","title":"ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer","status":"RECRUITING","sponsor":"National Cancer Institute, Naples","startDate":"2025-03-12","conditions":"Colorectal Cancer Metastatic","enrollment":130},{"nctId":"NCT07264309","phase":"NA","title":"Combined Intravenous Tramadol and Paracetamol Versus Intramuscular Pethidine for Pain Relief During the First Stage of Labor. Compare the Efficacy and Adverse Effects","status":"RECRUITING","sponsor":"Zohar Nachum","startDate":"2025-11-01","conditions":"Pain Management, Birth","enrollment":140},{"nctId":"NCT06677307","phase":"PHASE1, PHASE2","title":"A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110","status":"ACTIVE_NOT_RECRUITING","sponsor":"Korro Bio, Inc.","startDate":"2025-01-13","conditions":"Alpha-1 Anti-trypsin Deficiency, AATD","enrollment":64},{"nctId":"NCT02445651","phase":"NA","title":"Physiological Effects of Nutritional Support in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2014-03","conditions":"Parkinson Disease, Idiopathic Parkinson Disease","enrollment":51},{"nctId":"NCT06735755","phase":"PHASE1, PHASE2","title":"A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)","status":"RECRUITING","sponsor":"Beam Therapeutics Inc.","startDate":"2024-12-06","conditions":"Glycogen Storage Disease Type Ia","enrollment":36},{"nctId":"NCT00610051","phase":"PHASE3","title":"ALP-1 Continuous Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Biopeutics Co., Ltd","startDate":"2026-10","conditions":"End Stage Cardiac Failure, HFrEF - Heart Failure With Reduced Ejection Fraction, NYHF Class III-IV","enrollment":600},{"nctId":"NCT07025343","phase":"NA","title":"Does Intralipid Infusion Can Reverse the Spinal Anesthesia Effect in Day Case Surgery?","status":"COMPLETED","sponsor":"Benha University","startDate":"2025-02-01","conditions":"Intralipid Infusion, Spinal Anesthesia, Day Case Surgery","enrollment":200},{"nctId":"NCT06049680","phase":"PHASE4","title":"Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients","status":"RECRUITING","sponsor":"Fresenius Kabi","startDate":"2024-10-28","conditions":"Malnutrition, Child, Malnutrition, Essential Fatty Acid Deficiency (EFAD)","enrollment":100},{"nctId":"NCT04584983","phase":"PHASE2","title":"Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-02-11","conditions":"Bilirubin Encephalopathy","enrollment":134},{"nctId":"NCT06886464","phase":"PHASE2","title":"Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin","status":"RECRUITING","sponsor":"Matthew James","startDate":"2025-07-16","conditions":"Acute Kidney Injury","enrollment":698},{"nctId":"NCT04702256","phase":"PHASE3","title":"Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-12-09","conditions":"Lupus Nephritis, Systemic Lupus Erythematosus (SLE)","enrollment":196},{"nctId":"NCT01780844","phase":"PHASE2","title":"A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2013-03-05","conditions":"Kidney Transplantation","enrollment":149},{"nctId":"NCT05739643","phase":"PHASE1, PHASE2","title":"Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT","status":"ACTIVE_NOT_RECRUITING","sponsor":"Forge Biologics, Inc","startDate":"2023-02-03","conditions":"Krabbe Disease","enrollment":9},{"nctId":"NCT07162688","phase":"PHASE1, PHASE2","title":"Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation.","status":"ENROLLING_BY_INVITATION","sponsor":"Fujian Medical University","startDate":"2025-05-16","conditions":"Graft-Versus-Host Disease(GVHD)","enrollment":30},{"nctId":"NCT04185246","phase":"PHASE1, PHASE2","title":"A Dose Ascending Study to Evaluate the Safety of NH002 as a Contrast Agent in Cardiac Echocardiography","status":"COMPLETED","sponsor":"Trust Bio-sonics, Inc.","startDate":"2019-11-04","conditions":"Cardiac Disease","enrollment":36},{"nctId":"NCT06081283","phase":"PHASE4","title":"Antiseizure Medication in Seizure Networks at Early Acute Brain Injury","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2023-11-20","conditions":"Brain Injuries, Acute, Brain Injuries, Traumatic, Brain Ischemia","enrollment":5},{"nctId":"NCT07227207","phase":"PHASE1, PHASE2","title":"A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)","status":"NOT_YET_RECRUITING","sponsor":"Tessera Therapeutics, Inc.","startDate":"2025-12","conditions":"Alpha-1 Antitrypsin Deficiency (AATD)","enrollment":72},{"nctId":"NCT05204563","phase":"PHASE3","title":"Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2)","status":"COMPLETED","sponsor":"Evopoint Biosciences Inc.","startDate":"2022-07-31","conditions":"Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia","enrollment":450},{"nctId":"NCT00244816","phase":"PHASE2","title":"Taxoprexin® Treatment for Advanced Eye Melanoma","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-10","conditions":"Metastatic Melanoma","enrollment":22},{"nctId":"NCT05137119","phase":"PHASE4","title":"Staphylococcus Aureus Network Adaptive Platform Trial","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2022-02-16","conditions":"Staphylococcus Aureus Bacteremia","enrollment":8000},{"nctId":"NCT05703971","phase":"PHASE1, PHASE2","title":"Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients","status":"RECRUITING","sponsor":"Genprex, Inc.","startDate":"2024-05-09","conditions":"Small Cell Lung Cancer Extensive Stage","enrollment":62},{"nctId":"NCT00422877","phase":"PHASE2","title":"Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract","status":"TERMINATED","sponsor":"American Regent, Inc.","startDate":"2007-01","conditions":"Cancer of the Liver","enrollment":13},{"nctId":"NCT05090800","phase":"PHASE2","title":"Contrast Enhanced Ultrasound for Renal Obstruction","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2021-12-03","conditions":"Kidney; Obstruction, Renal Obstruction","enrollment":10},{"nctId":"NCT00249262","phase":"PHASE2","title":"Taxoprexin Treatment for Advanced Skin Melanoma","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-10","conditions":"Metastatic Melanoma","enrollment":30},{"nctId":"NCT07193953","phase":"PHASE1","title":"Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS)","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2025-04-15","conditions":"Amyotrophic Lateral Sclerosis, ALS","enrollment":6},{"nctId":"NCT05526066","phase":"PHASE2","title":"Study for Adolescents and Adults With Ornithine Transcarbamylase Deficiency to Evaluate Safety and Tolerability of ARCT-810","status":"TERMINATED","sponsor":"Arcturus Therapeutics, Inc.","startDate":"2022-10-17","conditions":"Ornithine Transcarbamylase Deficiency, OTC Deficiency, OTCD","enrollment":8},{"nctId":"NCT07179003","phase":"PHASE2","title":"A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-04","conditions":"Breast Abscess","enrollment":50},{"nctId":"NCT02512718","phase":"PHASE1","title":"Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Transplantation","status":"COMPLETED","sponsor":"Alexandra N. Carey","startDate":"2016-06","conditions":"Hematopoietic Stem Cell Transplantation","enrollment":20},{"nctId":"NCT06482853","phase":"EARLY_PHASE1","title":"Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2025-01-23","conditions":"Obesity, Hypertension","enrollment":52},{"nctId":"NCT05301192","phase":"EARLY_PHASE1","title":"Angiotensin-(1-7) Cardiovascular Effects in Aging","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2022-12-09","conditions":"Aging","enrollment":26},{"nctId":"NCT03777215","phase":"EARLY_PHASE1","title":"Angiotensin-(1-7) and Energy Expenditure in Human Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"Amy Arnold","startDate":"2019-09-26","conditions":"Obesity","enrollment":30},{"nctId":"NCT07183384","phase":"PHASE1, PHASE2","title":"MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction","status":"RECRUITING","sponsor":"Universitas Padjadjaran","startDate":"2024-07-01","conditions":"Preeclampsia, Postpartum, Endothelial Injury","enrollment":80},{"nctId":"NCT07179328","phase":"PHASE1","title":"Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2025-06-04","conditions":"GBM, Glioblastoma Multiforme (GBM), Glioblastoma Multiforme of Brain","enrollment":10},{"nctId":"NCT01810588","phase":"PHASE2","title":"Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2012-10-16","conditions":"Hematologic Malignancies","enrollment":270},{"nctId":"NCT05977868","phase":"PHASE4","title":"Comparing Oral Versus Parenteral Antimicrobial Therapy","status":"TERMINATED","sponsor":"West Virginia University","startDate":"2023-08-04","conditions":"Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection","enrollment":94},{"nctId":"NCT06815627","phase":"PHASE3","title":"Safety and Efficacy Evaluation of NH002 as a Contrast Agent in Subjects Undergoing Cardiac Echocardiography","status":"RECRUITING","sponsor":"Trust Bio-sonics, Inc.","startDate":"2025-03-18","conditions":"Cardiac Diseases","enrollment":150},{"nctId":"NCT00357565","phase":"PHASE2","title":"Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2005-11","conditions":"Leukemia, Myelodysplastic Syndromes, Childhood Acute Myeloid Leukemia in Remission","enrollment":34},{"nctId":"NCT07138898","phase":"PHASE2","title":"Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty","status":"NOT_YET_RECRUITING","sponsor":"NYU Langone Health","startDate":"2025-09","conditions":"Rheumatic Disease","enrollment":80},{"nctId":"NCT02412566","phase":"","title":"SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury","status":"APPROVED_FOR_MARKETING","sponsor":"Baylor College of Medicine","startDate":"","conditions":"Cholestasis, Growth Failure","enrollment":""},{"nctId":"NCT06822998","phase":"EARLY_PHASE1","title":"HF50 in HER-2 Positive and Low-expression Advanced Solid Tumors","status":"RECRUITING","sponsor":"HighField Biopharmaceuticals Corporation","startDate":"2025-06-11","conditions":"Advanced Solid Tumors","enrollment":10},{"nctId":"NCT05922124","phase":"PHASE4","title":"Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii","status":"RECRUITING","sponsor":"Rambam Health Care Campus","startDate":"2024-09-01","conditions":"Carbapenem Resistant Bacterial Infection, Acinetobacter Bacteremia, Acinetobacter Pneumonia","enrollment":734},{"nctId":"NCT00243867","phase":"PHASE3","title":"Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-11","conditions":"Non-Small Cell Lung Cancer","enrollment":518},{"nctId":"NCT03387579","phase":"PHASE3","title":"Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates","status":"COMPLETED","sponsor":"Indiana University","startDate":"2018-11-30","conditions":"Cholestasis of Parenteral Nutrition","enrollment":24},{"nctId":"NCT04117243","phase":"PHASE2","title":"Tranexamic Acid Versus Sublingual Misoprostol in Reducing Blood Loss During Elective CS in High Risk Cases","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-01-20","conditions":"Post Partum Hemorrhage","enrollment":345},{"nctId":"NCT05027984","phase":"NA","title":"Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS","status":"RECRUITING","sponsor":"Centro per la Lotta Contro l'Infarto - Fondazione Onlus","startDate":"2021-06-30","conditions":"Coronary Artery Disease, Coronary Disease, Ischemic Heart Disease","enrollment":1420},{"nctId":"NCT00087776","phase":"PHASE3","title":"Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma","status":"TERMINATED","sponsor":"American Regent, Inc.","startDate":"2002-12-06","conditions":"Malignant Melanoma","enrollment":393},{"nctId":"NCT04473911","phase":"PHASE1","title":"Haplo Peripheral Blood Sct In GVHD Prevention","status":"COMPLETED","sponsor":"Zachariah Michael DeFilipp","startDate":"2020-08-14","conditions":"GVHD, AML, ALL","enrollment":25}],"_emaApprovals":[],"_faersSignals":[{"count":3,"reaction":"SHOCK"},{"count":1,"reaction":"ACUTE LUNG INJURY"},{"count":1,"reaction":"CARDIOTOXICITY"},{"count":1,"reaction":"HYPERLIPIDAEMIA"},{"count":1,"reaction":"HYPOGLYCAEMIA"}],"_approvalHistory":[],"publicationCount":979,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"intravenous lipid","genericName":"intravenous lipid","companyName":"University of Rochester","companyId":"university-of-rochester","modality":"Small molecule","firstApprovalDate":"","aiSummary":"IMC-002 is a small molecule being studied as a potential treatment for various conditions, including Neuromyelitis Optica Spectrum Disorder (NMOSD), Bone Infection, Osteomyelitis, Septic Arthritis, and Joint Infection. The exact mechanism of IMC-002 is not specified in the available information, but it is classified as a small molecule.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}